Literature DB >> 27377316

Insights into Chronic Functional Movement Disorders: The Value of Qualitative Psychiatric Interviews.

Steven A Epstein1, Carine W Maurer2, Kathrin LaFaver3, Rezvan Ameli4, Stephen Sinclair5, Mark Hallett2.   

Abstract

BACKGROUND: Patients with functional movement disorders (FMDs) are commonly seen by neurologists and psychosomatic medicine psychiatrists. Research literature provides scant information about the subjective experiences of individuals with this often chronic problem.
OBJECTIVE: To enhance our understanding of psychologic aspects of FMDs by conducting qualitative interviews of research subjects.
METHODS: In total, 36 patients with FMDs were recruited from the Human Motor Control clinic at the National Institutes of Health. Each subject participated in a qualitative psychiatric interview and a structured diagnostic psychiatric interview.
RESULTS: Of our 36 subjects, 28 had current or lifetime psychiatric disorders in addition to conversion disorder and 22 had current disorders. Qualitative interviews provided rich information on patients' understanding of their illnesses and impaired cognitive processing of emotions.
CONCLUSION: Our study supports the addition of open-ended qualitative interviews to delineate emotional dynamics and conceptual frameworks among such patients. Exploratory interviews generate enhanced understanding of such complex patients, above and beyond that gained by assessing DSM diagnostic comorbidities.
Copyright © 2016 The Academy of Psychosomatic Medicine. All rights reserved.

Entities:  

Keywords:  conversion disorder; functional movement disorder; interview.; psychogenic movement disorder; qualitative

Mesh:

Year:  2016        PMID: 27377316      PMCID: PMC5086310          DOI: 10.1016/j.psym.2016.04.005

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  19 in total

1.  Emotional stimuli and motor conversion disorder.

Authors:  Valerie Voon; Christina Brezing; Cecile Gallea; Rezvan Ameli; Karin Roelofs; W Curt LaFrance; Mark Hallett
Journal:  Brain       Date:  2010-04-05       Impact factor: 13.501

Review 2.  Psychogenic movement disorders: a crisis for neurology.

Authors:  Mark Hallett
Journal:  Curr Neurol Neurosci Rep       Date:  2006-07       Impact factor: 5.081

3.  Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial.

Authors:  Katie Kompoliti; Burgess Wilson; Glenn Stebbins; Bryan Bernard; Vanessa Hinson
Journal:  Parkinsonism Relat Disord       Date:  2013-09-22       Impact factor: 4.891

4.  Psychopathology and psychogenic movement disorders.

Authors:  Sarah Kranick; Vindhya Ekanayake; Valeria Martinez; Rezvan Ameli; Mark Hallett; Valerie Voon
Journal:  Mov Disord       Date:  2011-06-28       Impact factor: 10.338

5.  Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol.

Authors:  Kathrin Czarnecki; Jeffrey M Thompson; Richard Seime; Yonas E Geda; Joseph R Duffy; J Eric Ahlskog
Journal:  Parkinsonism Relat Disord       Date:  2011-11-22       Impact factor: 4.891

Review 6.  Phenomenology and psychopathology related to psychogenic movement disorders.

Authors:  D T Williams; B Ford; S Fahn
Journal:  Adv Neurol       Date:  1995

7.  Multicenter pilot treatment trial for psychogenic nonepileptic seizures: a randomized clinical trial.

Authors:  W Curt LaFrance; Grayson L Baird; John J Barry; Andrew S Blum; Anne Frank Webb; Gabor I Keitner; Jason T Machan; Ivan Miller; Jerzy P Szaflarski
Journal:  JAMA Psychiatry       Date:  2014-09       Impact factor: 21.596

Review 8.  An update on psychogenic movement disorders.

Authors:  Aviva Ellenstein; Sarah M Kranick; Mark Hallett
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

9.  Impact of psychogenic movement disorders versus Parkinson's on disability, quality of life, and psychopathology.

Authors:  Karen E Anderson; Ann L Gruber-Baldini; Christopher G Vaughan; Stephen G Reich; Paul S Fishman; William J Weiner; Lisa M Shulman
Journal:  Mov Disord       Date:  2007-11-15       Impact factor: 10.338

10.  Neural correlates of recall of life events in conversion disorder.

Authors:  Selma Aybek; Timothy R Nicholson; Fernando Zelaya; Owen G O'Daly; Tom J Craig; Anthony S David; Richard A Kanaan
Journal:  JAMA Psychiatry       Date:  2014-01       Impact factor: 21.596

View more
  6 in total

Review 1.  The most promising advances in our understanding and treatment of functional (psychogenic) movement disorders.

Authors:  Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2017-07-08       Impact factor: 4.891

2.  [Functional neurological disorders: update and example of integrated inpatient treatment including mirror therapy].

Authors:  A Joos; R Halmer; N Leiprecht; K Schörner; C Lahmann; C Blahak
Journal:  Nervenarzt       Date:  2020-03       Impact factor: 1.214

3.  Gender as a Risk Factor for Functional Movement Disorders: The Role of Sexual Abuse.

Authors:  Isaiah Kletenik; Stefan H Sillau; Sanaz Attaripour Isfahani; Kathrin LaFaver; Mark Hallett; Brian D Berman
Journal:  Mov Disord Clin Pract       Date:  2019-12-13

4.  Gray matter differences in patients with functional movement disorders.

Authors:  Carine W Maurer; Kathrin LaFaver; Gaurang S Limachia; Geanna Capitan; Rezvan Ameli; Stephen Sinclair; Steven A Epstein; Mark Hallett; Silvina G Horovitz
Journal:  Neurology       Date:  2018-10-10       Impact factor: 9.910

Review 5.  Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.

Authors:  Bonnie M Kaas; Casey Jo Humbyrd; Alexander Pantelyat
Journal:  Mov Disord Clin Pract       Date:  2018-10-09

6.  Functional motor phenotypes: to lump or to split?

Authors:  Michele Tinazzi; Christian Geroin; Enrico Marcuzzo; Sofia Cuoco; Roberto Ceravolo; Sonia Mazzucchi; Andrea Pilotto; Alessandro Padovani; Luigi Michele Romito; Roberto Eleopra; Mario Zappia; Alessandra Nicoletti; Carlo Dallocchio; Carla Arbasino; Francesco Bono; Giuseppe Magro; Benedetta Demartini; Orsola Gambini; Nicola Modugno; Enrica Olivola; Laura Bonanni; Elisabetta Zanolin; Alberto Albanese; Gina Ferrazzano; Rosa De Micco; Leonardo Lopiano; Giovanna Calandra-Buonaura; Martina Petracca; Marcello Esposito; Antonio Pisani; Paolo Manganotti; Lucia Tesolin; Francesco Teatini; Tommaso Ercoli; Francesca Morgante; Roberto Erro
Journal:  J Neurol       Date:  2021-05-07       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.